XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total
Beginning balance, shares at Dec. 31, 2017 0 124,273,548        
Beginning balance, value at Dec. 31, 2017 $ 0 $ 124,274 $ 47,901,532 $ (40,843,568) $ (77,344) $ 7,104,894
Net income (loss)       (1,091,122)   (1,091,122)
Change in foreign currency translation         (41,595) (41,595)
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares   256,455        
Issuance of common stock in connection with the exercise of common stock purchase warrants, value   $ 256 61,244     61,500
Issuance of common stock as compensation to employees, officers and/or directors, shares   115,321        
Issuance of common stock as compensation to employees, officers and/or directors, value   $ 115 76,078     76,193
Issuance of common stock in exchange for consulting, professional and other services, shares   197,500        
Issuance of common stock in exchange for consulting, professional and other services, value   $ 197 138,178     138,375
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, shares   285,627        
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, value   $ 286 171,090     171,376
Issuance of common stock in connection with the issuance of convertible debentures, shares   186,566        
Issuance of common stock in connection with the issuance of convertible debentures, value   $ 187 109,652     109,839
Issuance of common stock in connection with the amendment of terms of promissory note(s), shares   800,000        
Issuance of common stock in connection with the amendment of terms of promissory note(s), value   $ 800 479,200     480,000
Recognition of beneficial conversion features related to convertible debentures     800     800
Ending balance, shares at Mar. 31, 2018 0 126,115,017        
Ending balance, value at Mar. 31, 2018 $ 0 $ 126,115 48,937,774 (41,934,690) (118,939) 7,010,260
Beginning balance, shares at Dec. 31, 2017 0 124,273,548        
Beginning balance, value at Dec. 31, 2017 $ 0 $ 124,274 47,901,532 (40,843,568) (77,344) 7,104,894
Net income (loss)           (2,445,009)
Change in foreign currency translation           (110,477)
Ending balance, shares at Jun. 30, 2018 0 127,328,822        
Ending balance, value at Jun. 30, 2018 $ 0 $ 127,329 49,493,776 (43,288,577) (187,821) 6,144,707
Beginning balance, shares at Mar. 31, 2018 0 126,115,017        
Beginning balance, value at Mar. 31, 2018 $ 0 $ 126,115 48,937,774 (41,934,690) (118,939) 7,010,260
Net income (loss)       (1,353,887)   (1,353,887)
Change in foreign currency translation         (68,882) (68,882)
Issuance of common stock as compensation to employees, officers and/or directors, shares   480,000        
Issuance of common stock as compensation to employees, officers and/or directors, value   $ 480 215,770     216,250
Issuance of common stock in exchange for consulting, professional and other services, shares   437,000        
Issuance of common stock in exchange for consulting, professional and other services, value   $ 438 196,437     196,875
Issuance of common stock in connection with the issuance of convertible debentures, shares   141,805        
Issuance of common stock in connection with the issuance of convertible debentures, value   $ 141 88,280     88,421
Issuance of common stock in connection with the amendment of terms of promissory note(s), shares   5,000        
Issuance of common stock in connection with the amendment of terms of promissory note(s), value   $ 5 2,245     2,250
Issuance of common stock in connection with the acquisition of a business, shares   150,000        
Issuance of common stock in connection with the acquisition of a business, value   $ 150 52,350     52,500
Stock based compensation expense related to stock options     920     920
Ending balance, shares at Jun. 30, 2018 0 127,328,822        
Ending balance, value at Jun. 30, 2018 $ 0 $ 127,329 49,493,776 (43,288,577) (187,821) 6,144,707
Beginning balance, shares at Dec. 31, 2018 0 138,553,655        
Beginning balance, value at Dec. 31, 2018 $ 0 $ 138,554 52,254,286 (45,457,207) (153,254) 6,782,379
Net income (loss)       (1,643,639)   (1,643,639)
Change in foreign currency translation         11,104 11,104
Issuance of Series A preferred stock in connection with sales made under private offerings, shares 800,000          
Issuance of Series A preferred stock in connection with sales made under private offerings, value $ 800   354,795     355,595
Issuance of common stock in connection with sales of Series A preferred stock, shares   4,000,000        
Issuance of common stock in connection with sales of Series A preferred stock, value   $ 4,000 440,405     444,405
Issuance of common stock in exchange for consulting, professional and other services, shares   1,377,338        
Issuance of common stock in exchange for consulting, professional and other services, value   $ 1,377 348,268     349,645
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, shares   99,720        
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, value   $ 100 26,840     26,940
Issuance of common stock in connection with the amendment of terms of promissory note(s), shares   800,000        
Issuance of common stock in connection with the amendment of terms of promissory note(s), value   $ 800 219,200     220,000
Beneficial conversion feature related to preferred stock     199,800     199,800
Deemed dividend on conversion of convertible preferred stock to common stock     (199,800)     (199,800)
Accretion of Series A preferred stock     440,405     440,405
Deemed dividend on accretion of Series A preferred stock     (440,405)     (440,405)
Ending balance, shares at Mar. 31, 2019 800,000 144,830,713        
Ending balance, value at Mar. 31, 2019 $ 800 $ 144,831 53,643,794 (47,100,846) (142,150) 6,546,429
Beginning balance, shares at Dec. 31, 2018 0 138,553,655        
Beginning balance, value at Dec. 31, 2018 $ 0 $ 138,554 52,254,286 (45,457,207) (153,254) 6,782,379
Net income (loss)           (2,756,893)
Change in foreign currency translation           21,070
Ending balance, shares at Jun. 30, 2019 925,000 147,268,620        
Ending balance, value at Jun. 30, 2019 $ 925 $ 147,269 54,079,515 (48,214,100) (132,184) 5,881,425
Beginning balance, shares at Mar. 31, 2019 800,000 144,830,713        
Beginning balance, value at Mar. 31, 2019 $ 800 $ 144,831 53,643,794 (47,100,846) (142,150) 6,546,429
Net income (loss)       (1,113,254)   (1,113,254)
Change in foreign currency translation         9,966 9,966
Issuance of Series A preferred stock in connection with sales made under private offerings, shares 125,000          
Issuance of Series A preferred stock in connection with sales made under private offerings, value $ 125   55,431     55,556
Issuance of common stock in connection with sales of Series A preferred stock, shares   625,000        
Issuance of common stock in connection with sales of Series A preferred stock, value   $ 625 68,819     69,444
Issuance of common stock in exchange for consulting, professional and other services, shares   499,444        
Issuance of common stock in exchange for consulting, professional and other services, value   $ 500 108,852     109,352
Issuance of common stock in connection with the issuance of convertible debentures, shares   80,130        
Issuance of common stock in connection with the issuance of convertible debentures, value   $ 80 18,852     18,932
Beneficial conversion feature related to preferred stock     31,250     31,250
Deemed dividend on conversion of convertible preferred stock to common stock     (31,250)     (31,250)
Accretion of Series A preferred stock     69,444     69,444
Deemed dividend on accretion of Series A preferred stock     (69,444)     (69,444)
Issuance of common stock in connection with sales made under private offerings, shares   1,233,333        
Issuance of common stock in connection with sales made under private offerings, value   $ 1,233 183,767     185,000
Ending balance, shares at Jun. 30, 2019 925,000 147,268,620        
Ending balance, value at Jun. 30, 2019 $ 925 $ 147,269 $ 54,079,515 $ (48,214,100) $ (132,184) $ 5,881,425